SVB Leerink analyst Puneet Souda maintains Hologic (NASDAQ:HOLX) with a Outperform and raises the price target from $90 to $93.
SVB Leerink Maintains Outperform on Hologic, Raises Price Target to $93
SVB Leerink analyst Puneet Souda maintains Hologic (NASDAQ:HOLX) with a Outperform and raises the price target from $90 to $93.
Related Posts
These Two Companies Teamed Up To ‘Become A Key Player In The Cannabis Marketing And Advertising Space’
Logiq, Inc. (OTCQX: LGIQ), a global provider of e-commerce and customer acquisition solutions, entered into a strategic alliance with MediaJel, Inc., a marketing platform primarily serving regulated industries.
Where RTX Stands With Analysts
Analysts have provided the following ratings for RTX (NYSE:RTX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…